SMPDL3B and metabolic dysfunction-associated steatotic liver disease: Taesik et al. found that macrophage-derived TSP1 inhibits the expression of SMPDL3B in the liver through an autocrine effect, increases the development of nonalcoholic fatty liver disease, and intensifies the liver’s proinflammatory signaling cascade [32].